Your Cart Is Empty!
Horizon Discovery is a revenue-generating life science company supplying research tools to organisations engaged in genomics research and the development of personalised medicines. Horizon has a diverse and international customer base of circa 1,000 organisations across circa 50 countries, including major pharmaceutical, biotechnology and diagnostic companies as well as leading academic research centers. The Company supplies its products and services into multiple markets, estimated to total in excess of £29 billion in 2015.
Horizon's core capabilities are built around its proprietary translational genomics platform, a high-precision and flexible suite of gene editing tools able to alter almost any endogenous gene sequence of human or mammalian cell-lines. Horizon offers in excess of 16,500 products, almost all of which are based on the application of gene editing to generate cell lines that accurately model the disease-causing mutations found in genetically based diseases. These 'patients-in-a-test-tube' are being used by customers to identify the effect of individual or compound genetic mutations on drug activity, patient responsiveness and resistance, which may lead to the successful prediction of which patient sub-groups will respond to currently available and future drug treatments.
Entering the post-genomic era: Translating genetic information into personalized medicine
Horizon aspires to provide science-driven research solutions that:
Send us a message
See our ordering page
Click here to register with us
More about shipping